Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Metastatic bronchopulmonary carcinoid

Filip Triest, Kristiaan Nackaerts, Christophe Dooms
European Respiratory Journal 2011 38: p2820; DOI:
Filip Triest
Internal Medicine, UZ Leuven, Leuven, Belgium Pneumology, UZ Leuven, Leuven, Belgium Pneumology, UZ Leuven, Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristiaan Nackaerts
Internal Medicine, UZ Leuven, Leuven, Belgium Pneumology, UZ Leuven, Leuven, Belgium Pneumology, UZ Leuven, Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christophe Dooms
Internal Medicine, UZ Leuven, Leuven, Belgium Pneumology, UZ Leuven, Leuven, Belgium Pneumology, UZ Leuven, Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Background: Bronchopulmonary carcinoids (BPCs) are rare neuroendocrine tumors. Metastatic BPC (M-BPC) represents less than 10% of all BPCs.

Aims: A retrospective study of a 5 years' consecutive series of M-BPC patients, treated in a tertiary referral center.

Methods: Demographics, symptoms, staging, pathology, therapy and survival were compared for non-metastatic (NM-) and M-BPC.

Results: Of 57 BPC patients, 12 (21%) had metastases. Five were truly metastatic at diagnosis. No differences were observed for age, smoking status and gender. Hemoptysis was mostly found in M-BPC (4/12); infection and absence of symptoms in NM-BPC (both 16/45). Somatostatin receptor imaging was performed in respectively 20% and 92%, FDG-PET in 67% and 75%, Ki-67 staining in 24% and 75%, chromogranin A staining in 64% and 83% of NM- and M-BPC patients. M-BPC was predominantly treated with chemotherapy (42%) and somatostatin analogues (58%), NM-BPC with surgery (91%). Median survival was 52 months for M-BPC, while not yet reached for NM-BPC patients (p=0.01).

Conclusions: In our center, a larger proportion of M-BPC patients was treated compared to literature. Major differences between NM-BPC and M-BPC were observed for treatment choices. Survival was significantly worse for M-BPC, although much better compared to more common lung cancer types.

  • © 2011 ERS
Previous
Back to top
Vol 38 Issue Suppl 55 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Metastatic bronchopulmonary carcinoid
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Metastatic bronchopulmonary carcinoid
Filip Triest, Kristiaan Nackaerts, Christophe Dooms
European Respiratory Journal Sep 2011, 38 (Suppl 55) p2820;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Metastatic bronchopulmonary carcinoid
Filip Triest, Kristiaan Nackaerts, Christophe Dooms
European Respiratory Journal Sep 2011, 38 (Suppl 55) p2820;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • A 55 year old man with bilateral pulmonary nodules, neuropathy and renal nodules
  • Primary posterior mediastinum epithelioid angiosarcoma complicated with pulmonary thromboembolism: A case report
Show more 288. Instructive clinical aspects of lung cancer

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society